CALCITRIOL

Calcitriol Adverse Events Reported to the FDA Over Time

How are Calcitriol adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Calcitriol, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Calcitriol is flagged as the suspect drug causing the adverse event.

Most Common Calcitriol Adverse Events Reported to the FDA

What are the most common Calcitriol adverse events reported to the FDA?

Hypercalcaemia	40 (4.06%)
Acute Myeloid Leukaemia	18 (1.83%)
Cardiovascular Disorder	16 (1.62%)
Nausea	15 (1.52%)
Dizziness	14 (1.42%)
Nephrolithiasis	13 (1.32%)
Asthenia	12 (1.22%)
Vomiting	12 (1.22%)
Abdominal Pain	11 (1.12%)
Confusional State	9 (.91%)
Death	9 (.91%)
	Show More
Milk-alkali Syndrome	9 (.91%)
Pain	9 (.91%)
Pain In Extremity	9 (.91%)
Blood Calcium Increased	8 (.81%)
Diarrhoea	8 (.81%)
Drug Ineffective	8 (.81%)
Hypocalcaemia	8 (.81%)
Nephrocalcinosis	8 (.81%)
Pyrexia	8 (.81%)
Renal Failure Acute	8 (.81%)
Adverse Event	7 (.71%)
Blood Urine Present	7 (.71%)
Coma	7 (.71%)
Convulsion	7 (.71%)
Enterococcal Infection	7 (.71%)
Renal Failure	7 (.71%)
Respiratory Distress	7 (.71%)
Staphylococcal Infection	7 (.71%)
Urinary Tract Infection	7 (.71%)
Weight Increased	7 (.71%)
Aplasia Pure Red Cell	6 (.61%)
Blood Alkaline Phosphatase Increase...	6 (.61%)
Decreased Appetite	6 (.61%)
Epistaxis	6 (.61%)
Headache	6 (.61%)
Hypertension	6 (.61%)
Infection	6 (.61%)
Paraesthesia	6 (.61%)
Syncope	6 (.61%)
Thrombosis	6 (.61%)
Arthritis	5 (.51%)
Blood Calcium Decreased	5 (.51%)
Blood Creatinine Increased	5 (.51%)
Blood Potassium Decreased	5 (.51%)
Bone Pain	5 (.51%)
Developmental Delay	5 (.51%)
Diabetes Mellitus	5 (.51%)
Fluid Retention	5 (.51%)
Haemorrhage	5 (.51%)
Hypoaesthesia	5 (.51%)
Lithotripsy	5 (.51%)
Neoplasm Malignant	5 (.51%)
Tinnitus	5 (.51%)
Transplant Rejection	5 (.51%)
Wheezing	5 (.51%)
Aspiration	4 (.41%)
Calciphylaxis	4 (.41%)
Chest Pain	4 (.41%)
Condition Aggravated	4 (.41%)
Continuous Positive Airway Pressure	4 (.41%)
Endometrial Disorder	4 (.41%)
Endometrial Hyperplasia	4 (.41%)
Femur Fracture	4 (.41%)
Medication Error	4 (.41%)
No Therapeutic Response	4 (.41%)
Oxygen Supplementation	4 (.41%)
Packed Red Blood Cell Transfusion	4 (.41%)
Post Herpetic Neuralgia	4 (.41%)
Product Taste Abnormal	4 (.41%)
Rash	4 (.41%)
Swelling	4 (.41%)
Thrombocytopenia	4 (.41%)
Thyroid Cancer	4 (.41%)
Weight Decreased	4 (.41%)
Abdominal Pain Upper	3 (.3%)
Alanine Aminotransferase Increased	3 (.3%)
Anaemia	3 (.3%)
Anxiety	3 (.3%)
Aspartate Aminotransferase Increase...	3 (.3%)
Bronchopneumonia	3 (.3%)
Calcinosis	3 (.3%)
Constipation	3 (.3%)
Device Related Infection	3 (.3%)
Electrocardiogram Pr Prolongation	3 (.3%)
Erythema	3 (.3%)
Fatigue	3 (.3%)
Haemoglobin Decreased	3 (.3%)
Haemolytic Anaemia	3 (.3%)
Hypercalciuria	3 (.3%)
Hypomagnesaemia	3 (.3%)
Leukopenia	3 (.3%)
Liver Function Test Abnormal	3 (.3%)
Muscle Spasms	3 (.3%)
Neutropenia	3 (.3%)
Oedema	3 (.3%)
Overdose	3 (.3%)
Pollakiuria	3 (.3%)
Pruritus	3 (.3%)
Renal Impairment	3 (.3%)
Repetitive Strain Injury	3 (.3%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Calcitriol, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Calcitriol is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Calcitriol

What are the most common Calcitriol adverse events reported to the FDA?

Neurological	64 (6.49%)
Bone, Calcium, Magnesium And Phosph...	59 (5.98%)
Gastrointestinal Signs	47 (4.77%)
Infections - Pathogen Unspecified	26 (2.64%)
Respiratory	26 (2.64%)
Water, Electrolyte And Mineral	25 (2.54%)
Therapeutic And Nontherapeutic Effe...	23 (2.33%)
Epidermal And Dermal Conditions	22 (2.23%)
Renal Disorders	22 (2.23%)
Urolithiases	21 (2.13%)
Bacterial Infectious	18 (1.83%)
	Show More
Cardiac Disorder Signs	18 (1.83%)
Leukemias	18 (1.83%)
Renal And Urinary Tract Investigati...	15 (1.52%)
Anemias Nonhemolytic And Marrow Dep...	14 (1.42%)
Appetite And General Nutritional	14 (1.42%)
Gastrointestinal Motility And Defec...	13 (1.32%)
Hematology Investigations	13 (1.32%)
Musculoskeletal And Connective Tiss...	13 (1.32%)
Cardiac Arrhythmias	12 (1.22%)
Electrolyte And Fluid Balance Condi...	12 (1.22%)
Physical Examination Topics	12 (1.22%)
Deliria	11 (1.12%)
Acid-base	10 (1.01%)
Body Temperature Conditions	10 (1.01%)
Bone Disorders	10 (1.01%)
Embolism And Thrombosis	10 (1.01%)
Hepatobiliary	10 (1.01%)
Medication Errors	10 (1.01%)
Seizures	10 (1.01%)
Cardiac And Vascular Investigations	9 (.91%)
Fatal Outcomes	9 (.91%)
Glucose Metabolism Disorders	9 (.91%)
Hepatic And Hepatobiliary	9 (.91%)
Injuries	9 (.91%)
Urinary Tract Signs	9 (.91%)
Product Quality Issues	8 (.81%)
Respiratory Tract Therapeutic Proce...	8 (.81%)
Therapeutic Procedures And Supporti...	8 (.81%)
Uterine, Pelvic And Broad Ligament	8 (.81%)
Cardiac Valve	7 (.71%)
Enzyme	7 (.71%)
Inner Ear And Viiith Cranial Nerve	7 (.71%)
Joint	7 (.71%)
White Blood Cell	7 (.71%)
Bronchial Disorders	6 (.61%)
Headaches	6 (.61%)
Upper Respiratory Tract Disorders	6 (.61%)
Vascular Hypertensive	6 (.61%)
Hematological And Lymphoid Tissue T...	5 (.51%)
Hemolyses And Related Conditions	5 (.51%)
Immune	5 (.51%)
Metabolic, Nutritional And Blood Ga...	5 (.51%)
Miscellaneous And Site Unspecified ...	5 (.51%)
Muscle	5 (.51%)
Myocardial	5 (.51%)
Platelet	5 (.51%)
Vascular Hemorrhagic	5 (.51%)
Anxiety Disorders	4 (.41%)
Bone And Joint Injuries	4 (.41%)
Endocrine Investigations	4 (.41%)
Endocrine Neoplasms Malignant And U...	4 (.41%)
Lower Respiratory Tract Disorders	4 (.41%)
Ocular Infections, Irritations And ...	4 (.41%)
Procedural And Device Related Injur...	4 (.41%)
Vascular	4 (.41%)
Congenital And Hereditary	3 (.3%)
Decreased And Nonspecific Blood Pre...	3 (.3%)
Exocrine Pancreas Conditions	3 (.3%)
Gastrointestinal Hemorrhages	3 (.3%)
Musculoskeletal And Connective Tiss...	3 (.3%)
Nephropathies	3 (.3%)
Oral Soft Tissue Conditions	3 (.3%)
Renal And Urinary Tract Therapeutic...	3 (.3%)
Salivary Gland Conditions	3 (.3%)
Thyroid Gland	3 (.3%)
Tissue	3 (.3%)
Administration Site Reactions	2 (.2%)
Allergic Conditions	2 (.2%)
Angiedema And Urticaria	2 (.2%)
Arteriosclerosis, Stenosis, Vascula...	2 (.2%)
Breast Neoplasms Malignant And Unsp...	2 (.2%)
Central Nervous System Vascular	2 (.2%)
Changes In Physical Activity	2 (.2%)
Chemical Injury And Poisoning	2 (.2%)
Coronary Artery	2 (.2%)
Dental And Gingival Conditions	2 (.2%)
Ear And Labyrinthine Disorders Cong...	2 (.2%)
Fungal Infectious	2 (.2%)
Gastrointestinal	2 (.2%)
Gastrointestinal Tract Disorders Co...	2 (.2%)
Heart Failures	2 (.2%)
Hematopoietic Neoplasms	2 (.2%)
Immunology And Allergy	2 (.2%)
Increased Intracranial Pressure And...	2 (.2%)
Injuries By Physical Agents	2 (.2%)
Mental Impairment	2 (.2%)
Movement Disorders	2 (.2%)
Neurological Disorders Congenital	2 (.2%)
Peritoneal And Retroperitoneal Cond...	2 (.2%)
Psychiatric	2 (.2%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Calcitriol, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Calcitriol is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.